The World Health Organization’s (WHO) independent experts have released a comprehensive review reaffirming that vaccines do not cause autism spectrum disorders (ASD), a conclusion supported by extensive global evidence. This review aims to address ongoing misinformation and highlight the crucial role of immunisation in public health.
Issued on December 11, 2025, by the Global Advisory Committee on Vaccine Safety (GACVS)—a panel of specialists established in 1999—the statement draws from systematic literature reviews of both recent and historical data. “Based on available evidence, no causal link exists between vaccines and autism spectrum disorders,” the committee asserted, reinforcing WHO’s longstanding position that childhood and prenatal vaccines are safe and not associated with ASD.
The review, conducted during a meeting on November 27, 2025, focused on the safety of two components in vaccines: thiomersal, an ethylmercury preservative used in some multi-dose vaccines, and aluminium adjuvants, which enhance immune responses. A review of 31 studies from 2010 to 2025, examining various cohorts and case-control data from multiple regions, found no association between thiomersal and ASD. Similarly, a 2025 Danish nationwide study involving 1,224,176 children born between 1997 and 2018, alongside studies from 1999 to 2023, found no connection between aluminium and autism or other chronic conditions.
These findings align with previous GACVS statements made in 2002, 2004, and 2012, which were in response to vaccine hesitancy following the controversial 1998 Lancet paper by Andrew Wakefield, which suggested a link between the MMR vaccine and autism. The study was retracted in 2010 due to fraud and ethical violations, and it has since been refuted by numerous large-scale investigations. For example, a 2019 Danish cohort study of 657,461 children found a 7% reduction in ASD risk among children who received the MMR vaccine compared to those who did not.
Despite this evidence, misinformation continues to fuel vaccine hesitancy. In Nigeria, ASD prevalence estimates range from 0.8% to 1.2%, with variations by region. Vaccine refusal linked to concerns about autism contributed to a 2024 measles outbreak, which resulted in over 16,000 suspected cases, 8,000 confirmed, and at least 70 deaths nationwide. WHO indicates that improved vaccination coverage could prevent an additional 1.5 million deaths annually from vaccine-preventable diseases.
The committee has urged authorities to base policies on robust scientific evidence, stressing that unfounded fears erode public trust in immunisation. “Global childhood immunisation efforts represent one of the greatest achievements in improving lives,” WHO emphasized, citing a 2024 Lancet analysis that estimated vaccines have prevented 154 million deaths over the past 50 years, primarily from measles.
Recent events have rekindled the vaccine-autism debate. On September 22, 2025, US President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. suggested that acetaminophen (Tylenol) use during pregnancy might contribute to autism, alongside calls to revise vaccine schedules. WHO responded promptly, stating that no evidence supports such claims for either acetaminophen or vaccines. A 2024 study published in JAMA, which compared sibling pairs, found no association between prenatal acetaminophen exposure and ASD, ADHD, or intellectual disabilities.
In Nigeria, DTP3 vaccine coverage was approximately 62% in 2023, with northern states such as Sokoto and Kano showing lower rates, leaving many children unvaccinated. Targeted community interventions, such as dialogues with local leaders, have successfully increased vaccine uptake in these regions.
The review also confirmed the safety of several vaccines, including those for HPV and rotavirus. The rise in ASD diagnoses worldwide is attributed to improved detection methods rather than environmental factors, with genetics accounting for up to 80% of the risk.
Under Nigeria’s National Strategy for Immunisation and Primary Health Care System Strengthening (2018–2028), the goal is to achieve high vaccination coverage to combat preventable diseases. This WHO endorsement provides vital support for health advocates, emphasizing that vaccines are a proven lifesaver, free from the unfounded autism associations that science has repeatedly debunked.
